NATICK, MA, USA Nisan 11, 2013
Cognex Launches New Version of Identification and Label Verification Software
In-Sight Track & Trace enables pharmaceutical serialization
Cognex Corporation (NASDAQ: CGNX), the world's leading supplier of machine vision systems, announced a new version of the In-Sight® Track & Trace identification and data verification solution for healthcare serialization. A follow up to successful deployments of In-Sight Track & Trace 1.0, this version includes enhancements that address additional requirements for pharmaceutical and medical device manufacturers to achieve unit-level product traceability.
Customers can use In-Sight Track & Trace 2.0 with multiple networked In-Sight vision systems to decode human-readable text along with 2-D and 1-D barcodes, including Data Matrix, GS1-128, GS1 DataBar, securPharm and Pharmacode.
“In-Sight Track & Trace is an off-the-shelf label verification and serialization software supplement for our pharmaceutical customers required to comply with GS1 and FDA regulations and similar laws worldwide,” says Herbert Lade, Vice President and Business Unit Manager, Vision Systems. He adds, “In the newest version, we incorporated bundling reading support, secondary authentication capability and our OCRMax™ tool for the highest read rates in the industry. This new feature provides superior read rates of human-readable dates, lot codes and serial numbers.”
The pre-programmed add-on software package needs little set up through a touch screen or HMI. In-Sight Track & Trace can be easily integrated into third-party serialization software or MES with industrial protocol support and built-in I/O controls. The technical controls needed for FDA 21 CFR Part 11 validation, including secure user authentication and automatic audit trail generation, are also included.
In-Sight Track & Trace 2.0 is available now.